11-819748-C-A
Variant summary
Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4BP7
The NM_020376.4(PNPLA2):c.30C>A(p.Ile10Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Synonymous variant affecting the same amino acid position (i.e. I10I) has been classified as Likely benign.
Frequency
Consequence
NM_020376.4 synonymous
Scores
Clinical Significance
Conservation
Publications
- neutral lipid storage myopathyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, ClinGen, Ambry Genetics, Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 0 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_020376.4. You can select a different transcript below to see updated ACMG assignments.
Ensembl Transcripts
| Sel. | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| PNPLA2 | TSL:1 MANE Select | c.30C>A | p.Ile10Ile | synonymous | Exon 2 of 10 | ENSP00000337701.4 | Q96AD5-1 | ||
| PNPLA2 | c.30C>A | p.Ile10Ile | synonymous | Exon 2 of 11 | ENSP00000539342.1 | ||||
| PNPLA2 | c.30C>A | p.Ile10Ile | synonymous | Exon 2 of 10 | ENSP00000539343.1 |
Frequencies
GnomAD3 genomes Cov.: 35
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1356030Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 668348
GnomAD4 genome Cov.: 35
ClinVar
Not reported inComputational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.